Analysis of Short-term (Operating) Activity Ratios
Quarterly Data
Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Becton, Dickinson & Co., short-term (operating) activity ratios (quarterly data)
Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
| Short-term activity ratio | Description | The company |
|---|---|---|
| Inventory turnover | An activity ratio calculated as cost of goods sold divided by inventory. | Becton, Dickinson & Co.’s inventory turnover ratio improved from Q1 2020 to Q2 2020 but then deteriorated significantly from Q2 2020 to Q3 2020. |
| Receivables turnover | An activity ratio equal to revenue divided by receivables. | Becton, Dickinson & Co.’s receivables turnover ratio deteriorated from Q1 2020 to Q2 2020 but then improved from Q2 2020 to Q3 2020 exceeding Q1 2020 level. |
| Working capital turnover | An activity ratio calculated as revenue divided by working capital. |
| Short-term activity ratio | Description | The company |
|---|---|---|
| Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Becton, Dickinson & Co.’s number of days of inventory outstanding improved from Q1 2020 to Q2 2020 but then deteriorated significantly from Q2 2020 to Q3 2020. |
| Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnover. | Becton, Dickinson & Co.’s number of days of receivables outstanding deteriorated from Q1 2020 to Q2 2020 but then improved from Q2 2020 to Q3 2020 exceeding Q1 2020 level. |
| Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Becton, Dickinson & Co.’s operating cycle improved from Q1 2020 to Q2 2020 but then deteriorated significantly from Q2 2020 to Q3 2020. |
Inventory Turnover
Becton, Dickinson & Co., inventory turnover calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||||
| Cost of products sold | 2,195 | 2,520 | 2,247 | 2,318 | 2,276 | 2,221 | 2,187 | 2,312 | 2,261 | 2,618 | 1,530 | 1,613 | 1,531 | 1,537 | 1,470 | 1,679 | 1,651 | 1,584 | 1,578 | 1,630 | 1,946 | 1,005 | 1,006 | 1,100 | 1,046 | 1,019 | 980 | ||||||||
| Inventories | 2,945 | 2,794 | 2,760 | 2,579 | 2,629 | 2,627 | 2,522 | 2,451 | 2,562 | 2,543 | 2,967 | 1,818 | 1,829 | 1,747 | 1,692 | 1,719 | 1,835 | 1,846 | 1,985 | 1,959 | 2,020 | 2,278 | 1,512 | 1,495 | 1,553 | 1,512 | 1,467 | ||||||||
| Short-term Activity Ratio | |||||||||||||||||||||||||||||||||||
| Inventory turnover1 | 3.15 | 3.35 | 3.28 | 3.49 | 3.42 | 3.42 | 3.72 | 3.56 | 3.13 | 2.87 | 2.09 | 3.38 | 3.40 | 3.63 | 3.77 | 3.78 | 3.51 | 3.65 | 3.10 | 2.85 | 2.50 | 1.82 | 2.76 | 2.77 | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Inventory Turnover, Competitors2 | |||||||||||||||||||||||||||||||||||
| Boston Scientific Corp. | — | 2.13 | 1.96 | 1.97 | 1.91 | 2.22 | 2.34 | 2.41 | 2.43 | 2.50 | 2.35 | 2.41 | 2.36 | 2.44 | 2.58 | 2.54 | 2.38 | 2.37 | 2.18 | 2.14 | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 3.79 | 3.26 | 3.09 | 4.87 | 4.04 | 4.08 | 4.24 | 4.60 | 4.25 | 4.27 | 4.27 | 4.42 | 4.21 | 4.37 | 4.34 | 4.42 | 4.87 | 3.96 | 4.17 | 4.68 | — | — | — | — | — | — | — | ||||||||
| Edwards Lifesciences Corp. | — | 1.47 | 1.73 | 1.74 | 1.74 | 1.59 | 1.49 | 1.55 | 1.61 | 1.63 | 1.56 | 1.58 | 1.58 | 1.71 | 1.93 | 2.01 | 1.90 | 1.92 | 1.86 | 1.82 | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 2.18 | 2.22 | 2.30 | 2.30 | 2.24 | 2.41 | 2.50 | 2.74 | 2.89 | 3.10 | 3.46 | 3.88 | 4.02 | 4.02 | 3.90 | 4.47 | 4.37 | 4.73 | 4.91 | 4.80 | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 2.34 | 2.35 | 2.37 | 2.44 | 2.35 | 2.39 | 2.42 | 2.53 | 2.42 | 2.52 | 2.65 | 2.78 | 2.48 | 2.45 | 2.50 | 2.63 | 2.75 | 2.47 | 2.25 | 1.82 | — | — | — | — | — | — | — | ||||||||
| Stryker Corp. | — | 1.50 | 1.55 | 1.58 | 1.56 | 1.54 | 1.56 | 1.58 | 1.57 | 1.64 | 1.64 | 1.73 | 1.67 | 1.78 | 1.85 | 1.89 | 1.75 | 1.75 | 1.88 | 2.04 | — | — | — | — | — | — | — | ||||||||
| Thermo Fisher Scientific Inc. | — | 3.93 | 4.14 | 4.22 | 4.23 | 4.30 | 4.37 | 4.49 | 4.46 | 4.47 | 4.21 | 3.86 | 3.45 | 4.29 | 4.36 | 4.48 | 4.09 | 4.59 | 4.39 | 4.62 | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q3 2020 Calculation
Inventory turnover
= (Cost of products soldQ3 2020
+ Cost of products soldQ2 2020
+ Cost of products soldQ1 2020
+ Cost of products soldQ4 2019)
÷ Inventories
= (2,195 + 2,520 + 2,247 + 2,318)
÷ 2,945 = 3.15
2 Click competitor name to see calculations.
| Short-term activity ratio | Description | The company |
|---|---|---|
| Inventory turnover | An activity ratio calculated as cost of goods sold divided by inventory. | Becton, Dickinson & Co.’s inventory turnover ratio improved from Q1 2020 to Q2 2020 but then deteriorated significantly from Q2 2020 to Q3 2020. |
Receivables Turnover
Becton, Dickinson & Co., receivables turnover calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||||
| Revenues | 3,855 | 4,253 | 4,225 | 4,585 | 4,350 | 4,195 | 4,160 | 4,403 | 4,278 | 4,222 | 3,080 | 3,167 | 3,035 | 2,969 | 2,922 | 3,232 | 3,198 | 3,067 | 2,986 | 3,060 | 3,120 | 2,051 | 2,051 | 2,202 | 2,157 | 2,072 | 2,015 | ||||||||
| Trade receivables, net | 1,993 | 2,160 | 2,074 | 2,345 | 2,220 | 2,279 | 2,216 | 2,319 | 2,243 | 2,293 | 2,000 | 1,744 | 1,749 | 1,569 | 1,518 | 1,618 | 1,618 | 1,574 | 1,513 | 1,618 | 1,645 | 1,572 | 1,031 | 1,187 | 1,204 | 1,130 | 1,113 | ||||||||
| Short-term Activity Ratio | |||||||||||||||||||||||||||||||||||
| Receivables turnover1 | 8.49 | 8.06 | 8.37 | 7.37 | 7.71 | 7.48 | 7.70 | 6.89 | 6.57 | 5.89 | 6.13 | 6.93 | 6.95 | 7.85 | 8.18 | 7.72 | 7.61 | 7.77 | 7.41 | 6.35 | 5.73 | 5.38 | 8.23 | 7.12 | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Receivables Turnover, Competitors2 | |||||||||||||||||||||||||||||||||||
| Boston Scientific Corp. | — | 6.97 | 6.84 | 5.87 | 5.79 | 5.89 | 6.13 | 6.11 | 6.12 | 5.99 | 5.87 | 5.84 | 6.01 | 6.03 | 6.01 | 5.70 | 5.90 | 5.74 | 5.94 | 5.86 | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 5.83 | 5.59 | 5.25 | 5.61 | 5.31 | 5.42 | 5.70 | 5.70 | 5.90 | 5.85 | 5.75 | 5.20 | 5.48 | 5.42 | 5.66 | 5.30 | 5.90 | 4.77 | 5.11 | 5.19 | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 7.32 | 8.56 | 8.73 | 6.94 | 6.65 | 6.38 | 7.03 | 5.46 | 6.15 | 6.49 | 6.95 | 6.11 | 6.40 | 5.97 | 6.74 | 6.29 | 6.07 | 6.27 | 7.51 | 6.05 | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 4.97 | 5.05 | 5.20 | 4.91 | 5.22 | 5.29 | 5.28 | 5.00 | 5.15 | 5.15 | 5.18 | 5.31 | 5.38 | 5.12 | 5.36 | 5.18 | 5.87 | 5.15 | 4.84 | 3.96 | — | — | — | — | — | — | — | ||||||||
| Stryker Corp. | — | 6.39 | 5.65 | 5.14 | 5.97 | 5.90 | 6.08 | 5.83 | 6.39 | 6.24 | 6.04 | 5.66 | 6.17 | 6.28 | 6.29 | 5.76 | 6.04 | 5.96 | 6.32 | 5.98 | — | — | — | — | — | — | — | ||||||||
| Thermo Fisher Scientific Inc. | — | 5.86 | 5.69 | 5.87 | 5.75 | 6.02 | 5.93 | 5.89 | 6.20 | 5.90 | 5.52 | 5.39 | 5.42 | 5.89 | 6.05 | 5.99 | 6.21 | 6.50 | 6.50 | 6.67 | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | 19.62 | 16.73 | 20.32 | 21.70 | 24.04 | 17.92 | 19.75 | 19.88 | 19.54 | 17.94 | 20.92 | 22.65 | 18.19 | 19.61 | 22.57 | 24.52 | 18.76 | 21.23 | 23.98 | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q3 2020 Calculation
Receivables turnover
= (RevenuesQ3 2020
+ RevenuesQ2 2020
+ RevenuesQ1 2020
+ RevenuesQ4 2019)
÷ Trade receivables, net
= (3,855 + 4,253 + 4,225 + 4,585)
÷ 1,993 = 8.49
2 Click competitor name to see calculations.
| Short-term activity ratio | Description | The company |
|---|---|---|
| Receivables turnover | An activity ratio equal to revenue divided by receivables. | Becton, Dickinson & Co.’s receivables turnover ratio deteriorated from Q1 2020 to Q2 2020 but then improved from Q2 2020 to Q3 2020 exceeding Q1 2020 level. |
Working Capital Turnover
Becton, Dickinson & Co., working capital turnover calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||||||||||||
| Current assets | 8,827 | 8,555 | 6,438 | 6,664 | 6,781 | 6,844 | 6,941 | 7,411 | 7,525 | 7,512 | 7,542 | 18,633 | 18,212 | 4,891 | 5,187 | 6,367 | 6,534 | 6,612 | 5,641 | 6,045 | 6,303 | 6,996 | 12,111 | 6,131 | 6,045 | 5,946 | 5,743 | ||||||||
| Less: Current liabilities | 6,067 | 8,755 | 6,726 | 5,655 | 6,237 | 7,108 | 7,145 | 7,216 | 6,106 | 4,426 | 4,895 | 3,342 | 3,273 | 4,018 | 4,570 | 4,400 | 4,219 | 4,380 | 4,529 | 4,386 | 4,517 | 4,497 | 2,081 | 2,235 | 2,093 | 2,016 | 1,997 | ||||||||
| Working capital | 2,760 | (200) | (288) | 1,009 | 544 | (264) | (204) | 195 | 1,419 | 3,086 | 2,647 | 15,291 | 14,939 | 873 | 617 | 1,967 | 2,315 | 2,232 | 1,112 | 1,659 | 1,786 | 2,499 | 10,030 | 3,896 | 3,952 | 3,930 | 3,746 | ||||||||
| Revenues | 3,855 | 4,253 | 4,225 | 4,585 | 4,350 | 4,195 | 4,160 | 4,403 | 4,278 | 4,222 | 3,080 | 3,167 | 3,035 | 2,969 | 2,922 | 3,232 | 3,198 | 3,067 | 2,986 | 3,060 | 3,120 | 2,051 | 2,051 | 2,202 | 2,157 | 2,072 | 2,015 | ||||||||
| Short-term Activity Ratio | |||||||||||||||||||||||||||||||||||
| Working capital turnover1 | 6.13 | — | — | 17.14 | 31.45 | — | — | 81.96 | 10.39 | 4.38 | 4.63 | 0.79 | 0.81 | 14.11 | 20.13 | 6.35 | 5.32 | 5.48 | 10.09 | 6.20 | 5.28 | 3.39 | 0.85 | 2.17 | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Working Capital Turnover, Competitors2 | |||||||||||||||||||||||||||||||||||
| Boston Scientific Corp. | — | 3.77 | 12.73 | — | 17.52 | 6.79 | 5.66 | — | — | — | — | — | — | — | — | — | 49.53 | 53.76 | 13.80 | 7.18 | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 3.14 | 2.80 | 6.74 | 0.87 | 1.28 | 2.86 | 3.56 | 8.83 | 8.29 | 8.36 | 7.15 | 8.91 | 9.52 | 8.49 | 54.35 | — | 10.51 | 5.95 | 8.16 | 12.34 | — | — | — | — | — | — | — | ||||||||
| Edwards Lifesciences Corp. | — | 2.38 | 2.55 | 2.09 | 2.11 | 2.39 | 2.22 | 2.64 | 2.20 | 2.35 | 2.46 | 3.04 | 1.81 | 1.88 | 2.20 | 1.74 | 1.75 | 1.82 | 1.91 | 1.59 | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 0.80 | 0.88 | 1.23 | 1.23 | 1.25 | 1.24 | 1.17 | 1.06 | 1.01 | 1.04 | 1.18 | 1.49 | 1.29 | 1.41 | 1.73 | 1.02 | 1.10 | 1.08 | 1.25 | 1.40 | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 2.03 | 2.13 | 2.16 | 2.26 | 2.54 | 2.30 | 2.24 | 2.32 | 1.90 | 2.02 | 3.11 | 2.79 | 3.01 | 2.24 | 1.84 | 1.75 | 1.47 | 1.26 | 1.08 | 0.93 | — | — | — | — | — | — | — | ||||||||
| Stryker Corp. | — | 1.68 | 2.28 | 2.14 | 3.13 | 3.35 | 3.32 | 2.76 | 3.53 | 3.87 | 4.17 | 2.76 | 2.72 | 2.43 | 2.21 | 2.40 | 2.51 | 2.48 | 1.24 | 2.24 | — | — | — | — | — | — | — | ||||||||
| Thermo Fisher Scientific Inc. | — | 2.69 | 3.54 | 4.48 | 5.40 | 6.70 | 6.10 | 5.44 | 5.47 | 6.61 | 8.75 | 8.82 | 10.94 | 8.08 | 9.64 | 8.48 | 6.10 | 21.93 | 80.21 | 10.64 | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q3 2020 Calculation
Working capital turnover
= (RevenuesQ3 2020
+ RevenuesQ2 2020
+ RevenuesQ1 2020
+ RevenuesQ4 2019)
÷ Working capital
= (3,855 + 4,253 + 4,225 + 4,585)
÷ 2,760 = 6.13
2 Click competitor name to see calculations.
| Short-term activity ratio | Description | The company |
|---|---|---|
| Working capital turnover | An activity ratio calculated as revenue divided by working capital. |
Average Inventory Processing Period
Becton, Dickinson & Co., average inventory processing period calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||||||||||||||||
| Inventory turnover | 3.15 | 3.35 | 3.28 | 3.49 | 3.42 | 3.42 | 3.72 | 3.56 | 3.13 | 2.87 | 2.09 | 3.38 | 3.40 | 3.63 | 3.77 | 3.78 | 3.51 | 3.65 | 3.10 | 2.85 | 2.50 | 1.82 | 2.76 | 2.77 | — | — | — | ||||||||
| Short-term Activity Ratio (no. days) | |||||||||||||||||||||||||||||||||||
| Average inventory processing period1 | 116 | 109 | 111 | 105 | 107 | 107 | 98 | 103 | 117 | 127 | 174 | 108 | 107 | 101 | 97 | 97 | 104 | 100 | 118 | 128 | 146 | 200 | 132 | 132 | — | — | — | ||||||||
| Benchmarks (no. days) | |||||||||||||||||||||||||||||||||||
| Average Inventory Processing Period, Competitors2 | |||||||||||||||||||||||||||||||||||
| Boston Scientific Corp. | — | 172 | 186 | 185 | 191 | 164 | 156 | 151 | 150 | 146 | 155 | 152 | 155 | 150 | 142 | 144 | 153 | 154 | 168 | 171 | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 96 | 112 | 118 | 75 | 90 | 89 | 86 | 79 | 86 | 86 | 86 | 83 | 87 | 84 | 84 | 83 | 75 | 92 | 88 | 78 | — | — | — | — | — | — | — | ||||||||
| Edwards Lifesciences Corp. | — | 248 | 211 | 210 | 210 | 229 | 246 | 236 | 227 | 223 | 234 | 231 | 230 | 213 | 189 | 182 | 193 | 190 | 197 | 201 | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 167 | 164 | 159 | 159 | 163 | 152 | 146 | 133 | 126 | 118 | 106 | 94 | 91 | 91 | 94 | 82 | 83 | 77 | 74 | 76 | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 156 | 155 | 154 | 150 | 156 | 153 | 151 | 144 | 151 | 145 | 138 | 131 | 147 | 149 | 146 | 139 | 133 | 148 | 162 | 200 | — | — | — | — | — | — | — | ||||||||
| Stryker Corp. | — | 244 | 235 | 231 | 234 | 237 | 233 | 231 | 232 | 223 | 222 | 211 | 218 | 206 | 197 | 193 | 209 | 208 | 194 | 179 | — | — | — | — | — | — | — | ||||||||
| Thermo Fisher Scientific Inc. | — | 93 | 88 | 87 | 86 | 85 | 84 | 81 | 82 | 82 | 87 | 95 | 106 | 85 | 84 | 82 | 89 | 80 | 83 | 79 | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q3 2020 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 3.15 = 116
2 Click competitor name to see calculations.
| Short-term activity ratio | Description | The company |
|---|---|---|
| Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Becton, Dickinson & Co.’s number of days of inventory outstanding improved from Q1 2020 to Q2 2020 but then deteriorated significantly from Q2 2020 to Q3 2020. |
Average Receivable Collection Period
Becton, Dickinson & Co., average receivable collection period calculation (quarterly data)
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||||||||||||||||
| Receivables turnover | 8.49 | 8.06 | 8.37 | 7.37 | 7.71 | 7.48 | 7.70 | 6.89 | 6.57 | 5.89 | 6.13 | 6.93 | 6.95 | 7.85 | 8.18 | 7.72 | 7.61 | 7.77 | 7.41 | 6.35 | 5.73 | 5.38 | 8.23 | 7.12 | — | — | — | ||||||||
| Short-term Activity Ratio (no. days) | |||||||||||||||||||||||||||||||||||
| Average receivable collection period1 | 43 | 45 | 44 | 50 | 47 | 49 | 47 | 53 | 56 | 62 | 60 | 53 | 53 | 46 | 45 | 47 | 48 | 47 | 49 | 57 | 64 | 68 | 44 | 51 | — | — | — | ||||||||
| Benchmarks (no. days) | |||||||||||||||||||||||||||||||||||
| Average Receivable Collection Period, Competitors2 | |||||||||||||||||||||||||||||||||||
| Boston Scientific Corp. | — | 52 | 53 | 62 | 63 | 62 | 60 | 60 | 60 | 61 | 62 | 62 | 61 | 60 | 61 | 64 | 62 | 64 | 61 | 62 | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 63 | 65 | 69 | 65 | 69 | 67 | 64 | 64 | 62 | 62 | 63 | 70 | 67 | 67 | 65 | 69 | 62 | 76 | 71 | 70 | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 50 | 43 | 42 | 53 | 55 | 57 | 52 | 67 | 59 | 56 | 52 | 60 | 57 | 61 | 54 | 58 | 60 | 58 | 49 | 60 | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 73 | 72 | 70 | 74 | 70 | 69 | 69 | 73 | 71 | 71 | 71 | 69 | 68 | 71 | 68 | 70 | 62 | 71 | 75 | 92 | — | — | — | — | — | — | — | ||||||||
| Stryker Corp. | — | 57 | 65 | 71 | 61 | 62 | 60 | 63 | 57 | 58 | 60 | 64 | 59 | 58 | 58 | 63 | 60 | 61 | 58 | 61 | — | — | — | — | — | — | — | ||||||||
| Thermo Fisher Scientific Inc. | — | 62 | 64 | 62 | 63 | 61 | 62 | 62 | 59 | 62 | 66 | 68 | 67 | 62 | 60 | 61 | 59 | 56 | 56 | 55 | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | — | 19 | 22 | 18 | 17 | 15 | 20 | 18 | 18 | 19 | 20 | 17 | 16 | 20 | 19 | 16 | 15 | 19 | 17 | 15 | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q3 2020 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 8.49 = 43
2 Click competitor name to see calculations.
| Short-term activity ratio | Description | The company |
|---|---|---|
| Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnover. | Becton, Dickinson & Co.’s number of days of receivables outstanding deteriorated from Q1 2020 to Q2 2020 but then improved from Q2 2020 to Q3 2020 exceeding Q1 2020 level. |
Operating Cycle
Becton, Dickinson & Co., operating cycle calculation (quarterly data)
No. days
| Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||||||||||||||||||||||||||||||
| Average inventory processing period | 116 | 109 | 111 | 105 | 107 | 107 | 98 | 103 | 117 | 127 | 174 | 108 | 107 | 101 | 97 | 97 | 104 | 100 | 118 | 128 | 146 | 200 | 132 | 132 | — | — | — | ||||||||
| Average receivable collection period | 43 | 45 | 44 | 50 | 47 | 49 | 47 | 53 | 56 | 62 | 60 | 53 | 53 | 46 | 45 | 47 | 48 | 47 | 49 | 57 | 64 | 68 | 44 | 51 | — | — | — | ||||||||
| Short-term Activity Ratio | |||||||||||||||||||||||||||||||||||
| Operating cycle1 | 159 | 154 | 155 | 155 | 154 | 156 | 145 | 156 | 173 | 189 | 234 | 161 | 160 | 147 | 142 | 144 | 152 | 147 | 167 | 185 | 210 | 268 | 176 | 183 | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Operating Cycle, Competitors2 | |||||||||||||||||||||||||||||||||||
| Boston Scientific Corp. | — | 224 | 239 | 247 | 254 | 226 | 216 | 211 | 210 | 207 | 217 | 214 | 216 | 210 | 203 | 208 | 215 | 218 | 229 | 233 | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 159 | 177 | 187 | 140 | 159 | 156 | 150 | 143 | 148 | 148 | 149 | 153 | 154 | 151 | 149 | 152 | 137 | 168 | 159 | 148 | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 217 | 207 | 201 | 212 | 218 | 209 | 198 | 200 | 185 | 174 | 158 | 154 | 148 | 152 | 148 | 140 | 143 | 135 | 123 | 136 | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 229 | 227 | 224 | 224 | 226 | 222 | 220 | 217 | 222 | 216 | 209 | 200 | 215 | 220 | 214 | 209 | 195 | 219 | 237 | 292 | — | — | — | — | — | — | — | ||||||||
| Stryker Corp. | — | 301 | 300 | 302 | 295 | 299 | 293 | 294 | 289 | 281 | 282 | 275 | 277 | 264 | 255 | 256 | 269 | 269 | 252 | 240 | — | — | — | — | — | — | — | ||||||||
| Thermo Fisher Scientific Inc. | — | 155 | 152 | 149 | 149 | 146 | 146 | 143 | 141 | 144 | 153 | 163 | 173 | 147 | 144 | 143 | 148 | 136 | 139 | 134 | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (filing date: 2020-08-06), 10-Q (filing date: 2020-05-07), 10-Q (filing date: 2020-02-06), 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q3 2020 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 116 + 43 = 159
2 Click competitor name to see calculations.
| Short-term activity ratio | Description | The company |
|---|---|---|
| Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Becton, Dickinson & Co.’s operating cycle improved from Q1 2020 to Q2 2020 but then deteriorated significantly from Q2 2020 to Q3 2020. |